Vivani Medical, Inc.

Vivani Medical, Inc.

VANI·NASDAQ

$1.28

+0.39%
HealthcareMedical - Devices

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

At a Glance

Live Snapshot
Market Cap$75.92M
EPS-0.4300
P/E Ratio-2.99
Earnings Date08/12/2026

vani

Total Stockholders' Equity

Last Annual Value

15.73M

3-Year CAGR

-29%

5-Year CAGR

52%

10-Year CAGR

-3%

Vivani Medical, Inc.

Vivani Medical, Inc. Competitors Analysis of Total Stockholders' Equity

VANI · NASDAQ
CompanyTotal Stockholders' Equity
CAGR 3Y
CAGR 5Y
CAGR 10Y
15.73M
-8.8%44.9%3.5% 
77.55M
158.3%40.1%46.6%
CLNN logo
Clene Inc.
NASDAQ:CLNN
-17.59M
N/AN/AN/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
39.20M
74.5%2.3%15.6%
23.63M
-25.8%-16.1%38.5%
54.12M
-23.0%-22.5%N/A
-5.73M
N/AN/AN/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
140.35M
-13.8%-12.2%9.0%
93.80M
78.8%39.1%N/A
172.61M
3.0%4.5%12.7%
139.69M
7.9%19.0%4.4%
Vivani Medical, Inc.

Vivani Medical, Inc. Fair Value Envelope

VANI · NASDAQ

Our analysis suggests that VANI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.285, this represents a potential HIDDEN relative to our calculated worth for Vivani Medical, Inc..

Intrinsic Value
Current Price: $1.285